Sevilay A.
- Country
- Belgium
- Department
- Oncology
Research Overview
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- Phase 3 Randomized Study of Gedatolisib Combination Therapy versus Standard Endocrine Therapy in HR‑Positive, HER2‑Negative Advanced Breast Cancer Post‑CDK4/6 Inhibitor
Data & Insights
Has run more than one trial at 273 of 543 partner sites.
Specializations
Breast Cancer Specialization
Investigator demonstrates extensive expertise in treating various forms of breast cancer, particularly focusing on HER2-positive breast carcinoma, triple-negative breast cancer (TNBC), and hormone receptor-positive breast cancer.
- Advanced metastatic breast cancer management
- HER2-targeted therapeutic approaches
- Hormone receptor-positive disease treatment
Special interest in novel therapeutic combinations and targeted treatment strategies for breast cancer subtypes.
Gynecologic Oncology
Active involvement in treating various gynecologic malignancies, with particular focus on ovarian cancer, endometrial carcinoma, and cervical cancer.
- Advanced ovarian cancer treatments
- Endometrial cancer therapeutic approaches
- Locally advanced cervical cancer management
Expertise in both early-stage and advanced gynecologic cancers using innovative therapeutic strategies.
Therapeutic Approaches
Specializes in implementing diverse treatment modalities including immunotherapy, targeted therapies, and combination treatment approaches.
- Molecular targeted therapeutics
- Immunotherapy applications
- Neoadjuvant treatment strategies
Focus on personalized medicine approaches based on molecular and genetic markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.